LondonA gene-expression screen flagged furosemide for amyotrophic lateral sclerosis.
It has already passed the safety testing that kills most drug programs for the disease.
Researchers screened 1,001 approved drugs against gene data from over 150,000 people to find the match.
Furosemide has no patent, so no company will fund the trial to prove it works.
Sources: Nature